Results 21 to 30 of about 42,998 (266)

Oral Tetrahydrocannabinol (THC):Cannabinoid (CBD) Cannabis Extract Adjuvant for Reducing Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial

open access: yesInternational Journal of Women's Health, 2023
Apichaya Sukpiriyagul,1 Ratiporn Chartchaiyarerk,1 Paluekpon Tabtipwon,1 Buppa Smanchat,1 Sinart Prommas,1 Kornkarn Bhamarapravatana,2 Komsun Suwannarurk3 1Department of Obstetrics and Gynecology, Bhumibol Adulyadej Hospital, Royal Thai Air Force Bangkok
Sukpiriyagul A   +6 more
doaj  

Identification of Phenotypic Characteristics in Three Chemotype Categories in the Genus Cannabis

open access: yesHortScience, 2021
Modern Cannabis cultivars are morphologically distinguished by their leaflet shapes (wide for “Indica” and narrow for “Sativa”) by users and breeders. However, there are no scientific bases or references for determining the shape of these leaflets.
Dan Jin   +3 more
doaj   +1 more source

The safety of lookalikes: a new THC beverage enhancer and a non-THC counterpart

open access: yesJournal of Cannabis Research, 2023
AbstractA new tetrahydrocannabinol (THC) beverage enhancer is available to medical and recreational cannabis consumers across the US. Beverage enhancers that do not contain THC, but instead contain flavored concentrates and/or other additives such as caffeine, are used by squirting the contents of a bottle into water, or other beverage of choice, ad ...
Geoffrey W. Brown   +2 more
openaire   +3 more sources

Systematics and Botanical Characteristics of Industrial Hemp Cannabis Sativa L

open access: yesJournal of Natural Fibers, 2022
The systematic affiliation of Cannabis has been controversial for many years. Without a doubt, today we know that they belong to the order Rosales, family Cannabaceae, genus Cannabis, species – C. sativa L., with both industrial hemp (C. sativa L.
Malgorzata Strzelczyk   +2 more
doaj   +1 more source

Cannabinoids in the Older Person: A Literature Review

open access: yesGeriatrics, 2020
Introduction: Medical cannabinoids have received significant mainstream media attention in recent times due to an evolving political and clinical landscape.
William Beedham   +4 more
doaj   +1 more source

"Medical cannabis" – compendium of pharmacist’s knowledge [PDF]

open access: yesFarmacja Polska, 2020
The year 2019 was a breakthrough in the availability of cannabis herb for Polish patients. Three months after being registered, the first dried hemp preparation hit the market. This fact has created new therapeutic options for patients.
Natalia Anna Piekuś-Słomka
doaj   +1 more source

Green rush and red warnings: Retrospective chart review of adverse events of interactions between cannabinoids and psychotropic drugs

open access: yesFrontiers in Pharmacology
AimOur objective was to systematically assess the prevalence and clinical features of adverse events related to interactions between cannabinoids and psychotropic drugs through a retrospective chart review.Methodology1586 adverse event reports were ...
Adrian Andrzej Chrobak   +4 more
doaj   +1 more source

Dose-Related Inhibition of Capsaicin Responses by Cannabinoids CBG, CBD, THC and their Combination in Cultured Sensory Neurons

open access: yesJournal of Pain Research, 2021
Uma Anand,1 Christian Oldfield,1 Barbara Pacchetti,2 Praveen Anand,1 Mikael H Sodergren1,2 1Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, W12 ONN, UK; 2EMMAC Life Sciences Ltd, London, UKCorrespondence: Uma AnandFaculty of ...
Anand U   +4 more
doaj  

Acute effects of Delta-9-Tetrahydrocannabinol on performance monitoring in healthy volunteers

open access: yesFrontiers in Behavioral Neuroscience, 2011
Rationale: The error-related negativity (ERN) is a negative event-related potential that occurs immediately after an erroneous response and is thought to reflect human performance monitoring.
Desiree eSpronk   +6 more
doaj   +1 more source

Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function

open access: yesFrontiers in Pharmacology, 2016
Currently, 25 states and Washington DC have enacted full medical marijuana (MMJ) programs while 18 states allow limited access to MMJ products. Limited access states permit low (or zero) tetrahydrocannabinol (THC) and high cannabidiol (CBD) products to ...
Staci A Gruber   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy